Amanote Research
Register
Sign In
P192 Aside From Age, Do Other Factors Increase the Risk of Hepatotoxicity in Patients Treated for Latent Tb Infection?
Thorax
- United Kingdom
doi 10.1136/thoraxjnl-2014-206260.321
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pulmonary
Respiratory Medicine
Date
November 10, 2014
Authors
C. Ma
J. Potter
H. Kunst
V. White
Publisher
BMJ
Related search
Latent TB Infection
The Singapore Family Physician
QuantiFERON-TB Gold Test for Screening Latent Tuberculosis Infection in Hemodialysis Patients
Tuberkuloz ve Toraks
Pulmonary
Critical Care
Respiratory Medicine
Surgery
Intensive Care Medicine
Genetic Variants in Antioxidant Pathway: Risk Factors for Hepatotoxicity in Tuberculosis Patients
Tuberculosis
Infectious Diseases
Immunology
Microbiology
Screening and Identification of a Six-Cytokine Biosignature for Detecting TB Infection and Discriminating Active From Latent TB
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Isoniazid Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Risk Factors of Latent Tuberculosis Among Hemodialysis Patients
Treatment of Latent TB: First Do No Harm
Expert Review of Anti-Infective Therapy
Virology
Infectious Diseases
Microbiology
Effect of Diabetes Mellitus on Risk of Latent TB Infection in a High TB Incidence Area: A Community-Based Study in Taiwan
BMJ Open
Medicine
Further Evidence Supporting Programmatic Screening For, and Treatment of Latent TB Infection (LTBI) in New Entrants to the UK From High TB Prevalence Countries
Thorax
Pulmonary
Respiratory Medicine
